Ajay J. Kirtane, MD, SM, is Professor of Medicine at Columbia University Irving Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease. In this video, he speaks about A Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN).A Summary Synopsis:RADIANCE-HTN is a two-cohort, randomized, double-blind, sham-controlled study (TRIO and SOLO) that aims to demonstrate the efficacy and document the safety of the Paradise Renal Denervation System in two hypertensive populations.In-depth description:The RADIANCE Solo cohort will consist of subjects with essential hypertension who are controlled on one or two antihypertensive medications or who are uncontrolled on 0-2 antihypertensive medications, whereas the RADIANCE Trio cohort will consist of subjects with treatment resistant hypertension who are on at least three antihypertensive medications. Before randomization, subjects will be hypertensive in the absence of hypertension medication (SOLO) or despite a stabilized, single tablet, triple, fixed dose antihypertensive treatment regimen (TRIO). - Hypertension - 715_600c9efaa3c99

Podcast Ajay J. Kirtane, MD, SM @ajaykirtane @ColumbiaMed #RADIANCEHTN RADIANCE-HTN Study

Podcast Ajay J. Kirtane, MD, SM @ajaykirtane @ColumbiaMed #RADIANCEHTN RADIANCE-HTN Study

6 months
54 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Ajay J. Kirtane, MD, SM, is Professor of Medicine at Columbia University Irving Medical Center and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease. In this video, he speaks about A Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN).

A Summary Synopsis:

RADIANCE-HTN is a two-cohort, randomized, double-blind, sham-controlled study (TRIO and SOLO) that aims to demonstrate the efficacy and document the safety of the Paradise Renal Denervation System in two hypertensive populations.

In-depth description:

The RADIANCE Solo cohort will consist of subjects with essential hypertension who are controlled on one or two antihypertensive medications or who are uncontrolled on 0-2 antihypertensive medications, whereas the RADIANCE Trio cohort will consist of subjects with treatment resistant hypertension who are on at least three antihypertensive medications. Before randomization, subjects will be hypertensive in the absence of hypertension medication (SOLO) or despite a stabilized, single tablet, triple, fixed dose antihypertensive treatment regimen (TRIO).

Up Next Autoplay